Por: Associated Press Health March 14, 2023
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30. Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded... + full article
ABC7 USA Health March 17, 2023
Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1.The move follows similar ones by Eli Lilly and... + más
Sanofi is the latest insulin maker to announce price cap | WPTV
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk | Forbes
Ars Technica USA Science March 15, 2023
Navigate Filter by topic Settings Front page layout Site theme - Mar 14, 2023 10:25 pm UTC / In this photo illustration, insulin pens manufactured by Novo Nordisk are displayed on March 14, 2023, in Miami, Florida. Share this story Heavyweight insulin maker Novo Nordisk said... + más
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
California latest to sue drug companies over insulin prices | ABC7
Forbes USA Business March 14, 2023
Topline Pharmaceutical heavyweight Novo Nordisk on Tuesday it is cutting prices for several insulin drugs in the U.S., following a similar move from drugmaker Eli Lilly as healthcare companies come under increasing pressure to lower prices for the lifesaving diabetes medication.... + más
Novo Nordisk to lower insulin prices by 75% | Fox Business
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly | CNBC
Orlando Sentinel USA Business March 14, 2023
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They... + más
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly | Forbes
Fox Business USA Business March 14, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues there will be 'great growth' in the pharmaceutical industry. Pharmaceutical giant Novo Nordisk will lower the cost of several of its by up to 75% next year. Effective January 2024, the list price for insulin... + más
CNBC USA Health March 14, 2023
In this articleNovo Nordisk Inc. NovoLog brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019.Alex Flynn Bloomberg Getty Images on Tuesday announced plans to slash the price of several insulin drugs by up to 75% in... + más
The Hill USA Politics March 14, 2023
Danish pharmaceutical company Novo Nordisk announced on Tuesday it would be lowering the prices of some of its insulin products in the U.S. by up to 75 percent, becoming the second company to take such action after Eli Lilly’s announcement earlier this month. Four of Novo... + más
About iurex | Privacy Policy | Disclaimer |